Vestmark Advisory Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Vestmark Advisory Solutions’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	2,248 +381	+20%	+$259K	0.01%	860
2026 Q1	$1.44M	Buy	1,867 +567	+44%	+$434K	0.02%	755
2025 Q4	$1M	Buy	+1,300	New	+$883K	0.01%	795
2024 Q3	–	Sell	-1,871	Closed	-$1.97M	–	584
2024 Q2	$1.97M	Buy	1,871 +371	+25%	+$360K	0.08%	241
2024 Q1	$1.44M	Sell	1,500 -435	-22%	-$414K	0.06%	278
2023 Q4	$401K	Buy	+1,935	New	+$1.59M	0.02%	370
2023 Q3	–	Sell	-575	Closed	-$413K	–	774
2023 Q2	$413K	Buy	575 +126	+28%	+$97.1K	0.02%	626
2023 Q1	$369K	Buy	449 +164	+58%	+$124K	0.02%	644
2022 Q4	$206K	Buy	+285	New	+$210K	0.01%	794
2022 Q2	–	Sell	-635	Closed	-$443K	–	911
2022 Q1	$443K	Buy	635 +74	+13%	+$46.8K	0.03%	582
2021 Q4	$354K	Buy	561 +97	+21%	+$59.6K	0.02%	652
2021 Q3	$281K	Buy	+464	New	+$288K	0.02%	689
2021 Q2	–	Sell	-1,188	Closed	-$562K	–	800
2021 Q1	$562K	Buy	1,188 +599	+102%	+$292K	0.05%	411
2020 Q4	$285K	Buy	+589	New	+$318K	0.03%	478
2019 Q2	–	Sell	-542	Closed	-$223K	–	562
2019 Q1	$223K	Buy	+542	New	+$223K	0.04%	473

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vestmark Advisory Solutions's REGN Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, buying an estimated $259K and bringing the position to 2,248 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #860.

Vestmark Advisory Solutions first reported a position in REGN in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.97M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Vestmark Advisory Solutions held 2,248 shares of Regeneron Pharmaceuticals worth $1.4M as of Q2 2026.
Vestmark Advisory Solutions bought 381 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $259K.
Regeneron Pharmaceuticals made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #860 holding.
Vestmark Advisory Solutions first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
Vestmark Advisory Solutions's Regeneron Pharmaceuticals position peaked at $1.97M in Q2 2024.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.